Published • loading... • Updated
Surge in unapproved GLP-1 drugs alarming poison control, safe medicine advocates
Summary by NBC Bay Area
5 Articles
5 Articles
Semaglutide and Tirzepatide are profoundly changing the treatment of type 2 diabetes and obesity. But their therapeutic success is creating a misunderstanding: to consider them simply as slimming drugs. Actually, when prescribed to a patient with diabetes or clinically significant obesity, we are faced with pharmacological therapies for chronic diseases, with [...] The article Boom buying slimming drugs, the alarm of experts: "I'm not an aesthet…
·Rome, Italy
Read Full Article
GLP-1 analogue drugs, such as semaglutide and liraglutide, have changed the treatment of obesity. The risk arises when they are bought without prescription or provenance, and applied without diagnosis.
Coverage Details
Total News Sources5
Leaning Left2Leaning Right2Center0Last UpdatedBias Distribution50% Left, 50% Right
Bias Distribution
- 50% of the sources lean Left, 50% of the sources lean Right
50% Right
L 50%
R 50%
Factuality
To view factuality data please Upgrade to Premium
